Navigation Links
Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Date:8/19/2007

(422) (6,783)

General and

administrative (2,607) (582) (3,189)

Depreciation and

amortization (312) (312)

Interest income 1,060 1,060

Interest expense (86) (86)

Change in fair value

of warrant liability - (86) (86)

Preferred stock accretion - (310) (310)

Summary:

Income (loss) before

income taxes: (8,306) (86) (310) (1,004) (9,706)

Net income (loss): (8,307) (86) (310) (1,004) (9,707)

Net income (loss) per

share - basic

and diluted: (1.17) (0.01) (0.04) (0.14) (1.37)

Weighted average

number of shares

outstanding: 7,083,748 7,083,748

Amicus Therapeutics, Inc

Statement of Operations Information for 3 months ending June 30, 2006

Change in

Fair

Value of Preferred Stock

Warrant Stock Deemed Compen- GAAP as

Non-GAAP Liability Accretion Dividend sation Reported

Income Statement

Classifications:

Research and

development (6,295) (396) (6,691)

General and

administrative (2,202) (361) (2,563)

Depreciation and

amortization (217) (217)

Interest income 448 448

Interest expense (73)
'/>"/>

SOURCE Amicus Therapeutics

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amicus Therapeutics Presents Positive Results From Phase 1 Clinical Studies of Plicera for Gaucher Disease
2. Amicus Therapeutics Presents Preclinical Data from Studies of Plicera for Gaucher Disease
3. Amicus Therapeutics Presents Data From Preclinical and Phase 1 Studies of Amigal for Fabry Disease
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
7. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
8. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
9. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
10. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
11. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)MADISON, N.J., Dec. 3 A genetic variation that may indicate a patient,s risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is
(Date:12/3/2009)WARRENDALE, Pa., Dec. 3 Radiology imaging leader MEDRAD, Inc. demonstrated PACS* injection-record integration capabilities at the November 2009 Radiology Society of North America in Chicago. The Co
(Date:12/3/2009)DURHAM, N.C., Dec. 3 In response to the increasingly critical role of healthcare information technologies in the evolving healthcare delivery system, Duke Medicine has created the Duke Center for Hea
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3MEDEX Launches New Travel Agency Travel Express 61588 1MEDEX Launches New Travel Agency Travel Express 61588 2Cleaning Up Indoor Air Quality 3A New Certification Standard for Cleaning Products Will Help Millions of People Make More Educated Choices 61585 1Cleaning Up Indoor Air Quality 3A New Certification Standard for Cleaning Products Will Help Millions of People Make More Educated Choices 61585 2Cleaning Up Indoor Air Quality 3A New Certification Standard for Cleaning Products Will Help Millions of People Make More Educated Choices 61585 3Women at risk from vitamin A deficiency 10779 1Women at risk from vitamin A deficiency 10779 2
(Date:12/4/2009)Dental tourism is a phenomenon that was started by people that were looking for an alternative to the high price of dental work in the US, Canada, and other countries. In their search for lower priced
(Date:12/4/2009)Increasing exercise, water and fruit consumption leads to success, study finds , , FRIDAY, Dec. 4 (HealthDay News) -- Increased exercise, reduced soda consumption and self-weighing are among
(Date:12/4/2009)BOSTON, Dec. 4 Substantial progress has been made over the last 15 years in the healthcare community,s ability to diagnose and treat epilepsy and its complications. Yet this progress in epilepsy man
(Date:12/4/2009)Research and surveillance urged for at-risk patient groups , , FRIDAY, Dec. 4 (HealthDay News) -- Some childhood cancers, particularly Ewing sarcomas and central nervous system tumors, carry t
(Date:12/4/2009)SEATTLE Cholesterol-lowering drugs known as statins are among the most prescribed medicines in the U.S. Now a new study by researchers at Fred Hutchinson Cancer Research Center indicates that statins
Breaking Medicine News(10 mins):Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:Teens Lose More Weight Using Healthy Strategies 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4Health News:Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD 2
...om migraine headaches may be at risk for brain // ...ain where the tissue has died. Researchers stu...to 60. They grouped the patients into categories o...ants had a brain magnetic resonance imaging, blood...
...ties worn by medical staff carry disease-causing b...cians, // physician assistants, medical students a...r data confirmed that nearly 50 percent of the nec..., it is a good opportunity to reevaluate what is b...
...udy researchers say, the ancient Eastern tradition...mphoma patients// who took part in yoga classes re...l group. The study was conducted among 39 lymph...ga classes while the other half were put on a wait...
...o sunlight may lead to age-related maculopathy, al...// disorder that can cause blindness. Researchers ...nd more than 2,700 patients for 10 years. Patients...ginning of the study were three-times as likely to...
... clot that develops deep in the vein. It can be fa... who require prolonged bed rest are vulnerable bec...on ,especially patients in intensive care and pati... of minimal clinical importance in less ill patien...
...wer socioeconomic groups, as measured by level of ...with // higher socioeconomic status, but their str...r health. While those with more education have mor...were ranked on the degree of severity. Adults with...
Other Medicine News:
MONOJECT Red/Yellow Mottled Stopper
MONOJECT Black Stopper
VACUETTE Paediatric Fluoride Tubes - Ridged (safety screw cap)
BD Vacutainer® Fluoride Tubes - Plastic
Medicine Products: